Literature DB >> 26869223

The CD44s splice isoform is a central mediator for invadopodia activity.

Pu Zhao1, Yilin Xu1, Yong Wei2, Qiong Qiu2, Teng-Leong Chew3, Yibin Kang2, Chonghui Cheng4.   

Abstract

The ability for tumor cells to spread and metastasize to distant organs requires proteolytic degradation of extracellular matrix (ECM). This activity is mediated by invadopodia, actin-rich membrane protrusions that are enriched for proteases. However, the mechanisms underlying invadopodia activity are not fully understood. Here, we report that a specific CD44 splice isoform, CD44s, is an integral component in invadopodia. We show that CD44s, but not another splice isoform CD44v, is localized in invadopodia. Small hairpin (sh)RNA-mediated depletion of CD44s abolishes invadopodia activity, prevents matrix degradation and decreases tumor cell invasiveness. Our results suggest that CD44s promotes cortactin phosphorylation and recruits MT1-MMP (also known as MMP14) to sites of matrix degradation, which are important activities for invadopodia function. Importantly, we show that depletion of CD44s inhibits breast cancer cell metastasis to the lung in animals. These findings suggest a crucial mechanism underlying the role of the CD44s splice isoform in breast cancer metastasis.
© 2016. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Breast cancer; CD44s; Invadopodia; Metastasis; Splice isoform

Mesh:

Substances:

Year:  2016        PMID: 26869223      PMCID: PMC6518308          DOI: 10.1242/jcs.171959

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  23 in total

1.  Internalized CD44s splice isoform attenuates EGFR degradation by targeting Rab7A.

Authors:  Wei Wang; Honghong Zhang; Sali Liu; Chung Kwon Kim; Yilin Xu; Lisa A Hurley; Ryo Nishikawa; Motoo Nagane; Bo Hu; Alexander H Stegh; Shi-Yuan Cheng; Chonghui Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

2.  Akt Signaling Is Sustained by a CD44 Splice Isoform-Mediated Positive Feedback Loop.

Authors:  Sali Liu; Chonghui Cheng
Journal:  Cancer Res       Date:  2017-05-22       Impact factor: 12.701

Review 3.  Influence of transcriptional variants on metastasis.

Authors:  Joice De Faria Poloni; Diego Bonatto
Journal:  RNA Biol       Date:  2018-07-24       Impact factor: 4.652

4.  Hyaluronan synthase 2 (HAS2) regulates cell phenotype and invadopodia formation in luminal-like breast cancer cells.

Authors:  Yumeng Sheng; Manlin Cao; Yiwen Liu; Yiqing He; Guoliang Zhang; Yan Du; Feng Gao; Cuixia Yang
Journal:  Mol Cell Biochem       Date:  2021-05-05       Impact factor: 3.396

Review 5.  Tumor Cell Invadopodia: Invasive Protrusions that Orchestrate Metastasis.

Authors:  Robert J Eddy; Maxwell D Weidmann; Ved P Sharma; John S Condeelis
Journal:  Trends Cell Biol       Date:  2017-04-12       Impact factor: 20.808

Review 6.  TGF-beta signaling in cancer: post-transcriptional regulation of EMT via hnRNP E1.

Authors:  Breege V Howley; Philip H Howe
Journal:  Cytokine       Date:  2018-02-01       Impact factor: 3.861

7.  A Novel Invadopodia-Specific Marker for Invasive and Pro-Metastatic Cancer Stem Cells.

Authors:  Shenq-Shyang Huang; Wen-Ying Liao; Chung-Chi Hsu; Tze-Sian Chan; Tai-Yan Liao; Pei-Ming Yang; Li-Tzong Chen; Shian-Ying Sung; Kelvin K Tsai
Journal:  Front Oncol       Date:  2021-05-31       Impact factor: 6.244

8.  RNA G-quadruplex secondary structure promotes alternative splicing via the RNA-binding protein hnRNPF.

Authors:  Huilin Huang; Jing Zhang; Samuel E Harvey; Xiaohui Hu; Chonghui Cheng
Journal:  Genes Dev       Date:  2017-12-21       Impact factor: 11.361

9.  WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition.

Authors:  Chandra Prakash Prasad; Shivendra Kumar Chaurasiya; William Guilmain; Tommy Andersson
Journal:  J Exp Clin Cancer Res       Date:  2016-09-13

10.  Development of a novel method for rapid cloning of shRNA vectors, which successfully knocked down CD44 in mesenchymal triple-negative breast cancer cells.

Authors:  Lei Zhou; Dandan Sheng; Qiaodan Deng; Dong Wang; Suling Liu
Journal:  Cancer Commun (Lond)       Date:  2018-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.